Candoria Holding AG – Trademark Portfolio

Entity Type: 98

Candoria Holding AG holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes.

Dorfstrasse 38

CH-6340 Baar

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Candoria Holding AG's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Candoria Holding AG have?

Candoria Holding AG has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Candoria Holding AG file in?

Candoria Holding AG files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Candoria Holding AG's trademark registration success rate?

Candoria Holding AG has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.